Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy
Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy
About this item
Full title
Author / Creator
Henrich, Timothy J. , Hobbs, Kristen S. , Hanhauser, Emily , Scully, Eileen , Hogan, Louise E. , Robles, Yvonne P. , Leadabrand, Kaitlyn S. , Marty, Francisco M. , Palmer, Christine D. , Jost, Stephanie , Körner, Christian , Li, Jonathan Z. , Gandhi, Rajesh T. , Hamdan, Ayad , Abramson, Jeremy , LaCasce, Ann S. and Kuritzkes, Daniel R.
Publisher
US: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Background. Systemic chemotherapies for various malignancies have been shown to significantly, yet transiently, decrease numbers of CD4+ T lymphocytes, a major reservoir for human immunodeficiency virus type 1 (HIV-1) infection. However, little is known about the impact of cytoreductive chemotherapy on HIV-1 reservoir dynamics, persistence, and imm...
Alternative Titles
Full title
Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy
Authors, Artists and Contributors
Author / Creator
Hobbs, Kristen S.
Hanhauser, Emily
Scully, Eileen
Hogan, Louise E.
Robles, Yvonne P.
Leadabrand, Kaitlyn S.
Marty, Francisco M.
Palmer, Christine D.
Jost, Stephanie
Körner, Christian
Li, Jonathan Z.
Gandhi, Rajesh T.
Hamdan, Ayad
Abramson, Jeremy
LaCasce, Ann S.
Kuritzkes, Daniel R.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5853412
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5853412
Other Identifiers
ISSN
0022-1899
E-ISSN
1537-6613
DOI
10.1093/infdis/jix265
